Tritonpoint Wealth, LLC Castle Biosciences Inc Transaction History
Tritonpoint Wealth, LLC
- $1.05 Trillion
- Q1 2025
A detailed history of Tritonpoint Wealth, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 41,637 shares of CSTL stock, worth $895,611. This represents 0.08% of its overall portfolio holdings.
Number of Shares
41,637
Previous 46,637
10.72%
Holding current value
$895,611
Previous $1.24 Billion
32.93%
% of portfolio
0.08%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding CSTL
# of Institutions
208Shares Held
25.8MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$65.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$39.4 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$38.6 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$30.9 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$21.5 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $566M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...